Work

Surveillance Mammography in Older Patients With Breast Cancer—Can We Ever Stop?: A Review

Year: 2020

Type: article

Abstract: Approximately 4–5% of breast cancer survivors will develop a new ipsilateral or contralateral cancer (“in-breast event”) over the 5 years following diagnosis, and annual surveillance mammography is recommended for those with residual breast tissue. The risk for such in-breast events persists over time, though increasing age at cancer diagnosis and treatment with hormonal therapy are associated with lower risk, and most older breast cancer survivors will ultimately die from non-breast cancer related causes. Specific guidelines for surveillance strategies in older patients are limited. Prospective data on the benefits and harms of surveillance mammography in this population are lacking, and most of the evidence is derived from observational, retrospective data, often in the general population.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/k3hz-4z39

Authors: Winer, Eric P., Muss, Hyman B., Hurria, Arti, Keating, Nancy L., Partridge, Ann H., Freedman, Rachel A.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Digital Radiography and Breast Imaging

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, Sanofi, Celgene, National Cancer Institute